MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Exclusion Criteria

• •1. Patients who had received treatment Acute rejection within 4 weeks
• •2. Patients who had discontinued corticosteroid within 4 weeks
• •3. At the time of Screening
• •* Treatment with active liver disease or Liver function test(T-bilirubin, AST, ALT)is over 3 times than upper normal limit
• •* WBC\< 2,500/mm\^3, or platelet \< 75,000/mm\^3, or ANC \< 1,300/ mm\^3
• •4. In investigator's judgement